•
Mar 31

Cardlytics Q1 2025 Earnings Report

Cardlytics announced financial results for the first quarter ended March 31, 2025.

Key Takeaways

Cardlytics reported a decrease in revenue and billings for the first quarter of 2025 compared to the same period in the previous year. While net loss improved, Adjusted EBITDA and Adjusted Net Loss worsened. The company saw an increase in monthly qualified users but a decrease in adjusted contribution per user.

Revenue for Q1 2025 was $61.9 million, an 8% decrease year-over-year.

Net Loss for Q1 2025 was $(13.3) million, an improvement from $(24.3) million in Q1 2024.

Monthly Qualified Users (MQUs) increased by 12% year-over-year to 214.9 million.

Adjusted Contribution per user (ACPU) decreased to $0.13 from $0.17 in Q1 2024.

Total Revenue
$61.9M
Previous year: $67.6M
-8.4%
EPS
-$0.21
Previous year: -$0.09
+133.3%
Monthly Qualified Users
214.9M
Previous year: 191.21M
+12.4%
Adjusted Contribution Per User
$0.13
Previous year: $0.17
-23.5%
Billings
$97.6M
Previous year: $105M
-7.3%
Gross Profit
$25.2M
Previous year: $30.9M
-18.6%
Cash and Equivalents
$52M
Previous year: $97.8M
-46.8%
Free Cash Flow
-$10.8M
Previous year: -$22.4M
-51.7%
Total Assets
$369M
Previous year: $569M
-35.1%

Cardlytics

Cardlytics

Forward Guidance

For the second quarter of 2025, Cardlytics expects Billings between $100.0 million and $108.0 million, Revenue between $61.0 million and $67.0 million, Adjusted Contribution between $32.5 million and $36.5 million, and Adjusted EBITDA between $(4.0) million and $1.0 million.

Positive Outlook

  • Anticipated Billings range of $100.0 - $108.0 million for Q2 2025.
  • Anticipated Revenue range of $61.0 - $67.0 million for Q2 2025.
  • Anticipated Adjusted Contribution range of $32.5 - $36.5 million for Q2 2025.
  • Anticipated Adjusted EBITDA range of $(4.0) - $1.0 million for Q2 2025.
  • Potential for positive Adjusted EBITDA in Q2 2025.

Challenges Ahead

  • Anticipated year-over-year decrease in Billings for Q2 2025 (9% - 2%).
  • Anticipated year-over-year decrease in Revenue for Q2 2025 (12% - 4%).
  • Anticipated year-over-year decrease or flat Adjusted Contribution for Q2 2025 (11% - 0%).
  • Potential for negative Adjusted EBITDA in Q2 2025.
  • Reconciliation of forward-looking non-GAAP measures to GAAP is not available without unreasonable efforts.